128 related articles for article (PubMed ID: 1524919)
1. Neoadjuvant chemotherapy in 126 operable breast cancers.
Bélembaogo E; Feillel V; Chollet P; Curé H; Verrelle P; Kwiatkowski F; Achard JL; Le Bouëdec G; Chassagne J; Bignon YJ
Eur J Cancer; 1992; 28A(4-5):896-900. PubMed ID: 1524919
[TBL] [Abstract][Full Text] [Related]
2. [First-line chemotherapy in operable breast neoplasms: results of 3 protocols].
Cure H; Charrier S; Ferrière JP; Van Praagh I; Assier I; Feillel V; De Latour M; Bay JO; Achard JL; Dauplat J; Chollet P
Bull Cancer; 1997 Jan; 84(1):31-4. PubMed ID: 9180856
[TBL] [Abstract][Full Text] [Related]
3. Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer.
Touboul E; Lefranc JP; Blondon J; Buffat L; Deniaud E; Belkacémi Y; Benmiloud M; Huart J; Laugier A; Schlienger M
Radiother Oncol; 1997 Mar; 42(3):219-29. PubMed ID: 9155070
[TBL] [Abstract][Full Text] [Related]
4. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
[TBL] [Abstract][Full Text] [Related]
6. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
[TBL] [Abstract][Full Text] [Related]
7. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
Gianni L; Baselga J; Eiermann W; Guillem Porta V; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Llombart Cussac A; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez Lopez JJ; Mansutti M; Valagussa P; Bonadonna G;
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8715-21. PubMed ID: 16361558
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy in breast cancer.
Dorr A
Curr Opin Oncol; 1990 Dec; 2(6):1049-52. PubMed ID: 2099836
[No Abstract] [Full Text] [Related]
10. Locally advanced breast cancer: is surgery warranted following chemotherapy?
Kent AL; Eaton M; Marshall N; Humeniuk V
Aust N Z J Surg; 1995 Apr; 65(4):229-32. PubMed ID: 7717939
[TBL] [Abstract][Full Text] [Related]
11. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
[TBL] [Abstract][Full Text] [Related]
12. Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer.
Armstrong DK; Fetting JH; Davidson NE; Gordon GB; Huelskamp AM; Abeloff MD
Breast Cancer Res Treat; 1993 Dec; 28(3):277-84. PubMed ID: 8018956
[TBL] [Abstract][Full Text] [Related]
13. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
15. Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II).
Zambetti M; Mansutti M; Gomez P; Lluch A; Dittrich C; Zamagni C; Ciruelos E; Pavesi L; Semiglazov V; De Benedictis E; Gaion F; Bari M; Morandi P; Valagussa P; Luca G
Breast Cancer Res Treat; 2012 Apr; 132(3):843-51. PubMed ID: 21750964
[TBL] [Abstract][Full Text] [Related]
16. The use of mammography in breast preservation in locally advanced breast cancer.
Pierce L; Adler D; Helvie M; Lichter A; Merajver S
Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):571-7. PubMed ID: 8621280
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
[TBL] [Abstract][Full Text] [Related]
18. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.
Bonadonna G; Veronesi U; Brambilla C; Ferrari L; Luini A; Greco M; Bartoli C; Coopmans de Yoldi G; Zucali R; Rilke F
J Natl Cancer Inst; 1990 Oct; 82(19):1539-45. PubMed ID: 2402015
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.
Gianni L; Eiermann W; Semiglazov V; Manikhas A; Lluch A; Tjulandin S; Zambetti M; Vazquez F; Byakhow M; Lichinitser M; Climent MA; Ciruelos E; Ojeda B; Mansutti M; Bozhok A; Baronio R; Feyereislova A; Barton C; Valagussa P; Baselga J
Lancet; 2010 Jan; 375(9712):377-84. PubMed ID: 20113825
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative intensive chemotherapy of operable breast cancer].
Zhang B
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):228-30. PubMed ID: 2558871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
